Press Releases

• • •

• • •

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the fourth quarter and financial year 2024. Recent Financial and Operating Highlights Revenue for the fourth quarter of 2024 was €1.3 million, which

• • • Read More • • •

OCTO has been selected by ABAX Group as its New Risk Scoring Partner for UBI Insurance

LARVIK, Norway, March 11, 2025 (GLOBE NEWSWIRE) — Following an extensive six-month RFP process, ABAX Group AS announced today that its insurance division, “Fair” has selected OCTO Telematics, a leading global provider of AI and risk scoring solutions, to support its rapidly growing portfolio of Usage-Based Insurance (UBI) customers. This strategic partnership enhances its insurance product with improved AI-powered

• • • Read More • • •

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the

• • • Read More • • •

RECENT POSTS